The Vice Chancellor-Prof. Barnabas Nawangwe (Centre) and Principal CHS-Prof. Bruce Kirenga (Green Cap) with some of the 16 PHO Fellows at the Award Ceremony on 30th July 2025.
Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH), established the Paediatric Haematology and Oncology Fellowship (PHO) Program to build capacity and strengthen care for children with cancer and blood disorders across the country and the region.
Since its inception in 2016, 24 pediatricians have been trained by the program and now serve as leaders in Paediatric Haematology and Oncology clinical services across ten hospitals in seven countries in Africa. This marks a remarkable transformation from just two trained paediatric oncologists in Uganda in 2016 and has contributed to significantly improved survival rates for children with cancer and blood disorders.
On the 30th July 2025, 16 Fellows of the PHO Fellowship received their awards after a two-year stint on the fellowship. Below are their profiles
2018/2020 Cohort
Dr. Nana Nakiddu is a Paediatric Haematologist and Oncologist and lecturer at Muhimbili University of Health and Allied Sciences/Muhimbili National Hospital in Tanzania. Her career focus is on developing innovative models for the delivery of childhood cancer survivorship care in low- and middle-income countries, particularly in sub-Saharan Africa, where cancer survivorship care is still in its early stages despite major advancements in access to diagnosis and treatment. Her ultimate career goal is to lead research and care initiatives for the growing population of childhood cancer survivors across Africa. She is passionate about sports and has represented Uganda internationally in swimming. As a qualified sports medicine physician, she contributes to the field both nationally and globally. She currently serves as the Secretary General of the Uganda Society for Sports Medicine and is the immediate past chairperson of the Uganda Olympic Committee’s Medical and Anti-Doping Commission.
Dr. Heronima Joas Kashaigili is a Pediatric Hematologist and Oncologist at Bugando Medical Centre and a lecturer Catholic University of Health and Allied Sciences in Mwanza Tanzania. She is the Assistant Head of Oncology Services and leads the Pediatric Hematology and Oncology Unit at Bugando Medical Centre. She is recognized nationally as a mentor and leader in advancing pediatric cancer care to improve survival outcomes through capacity-building initiatives.
Dr. Kashaigili earned her medical degree from the Catholic University of Allied and Health Sciences in 2009. She specialized in Pediatrics and Child Health at Kilimanjaro Christian Medical College in 2017 and completed a fellowship in Pediatric Hematology and Oncology at Makerere University College of Health Sciences in 2020 with support from the Texas Children’s Global HOPE program. She also has training and experience in clinical research and is currently pursuing a Master of Science in Global Child Health (MSGCH).
Dr. Deborah Omeddo is a Paediatric haematologist and oncologist at Kisii teaching and Referral hospital and an adjunct lecturer at both the Kenya Medical Training college and Kisii University in Kenya. She has practiced as a paediatrician for the last 15 years during which she has keenly participated in research and clinical care of children. She has a passion for childhood haematological care and especially in Sickle cell disease. She has been a keen advocate for access of affordable care for sickle cell disease patients and is a patron of a number of the Sickle cell disease foundations. She has served in the Kenya paediatric association board where she advocated for childhood malnutrition and access to nutritional supplements. She is a member of the Kenyan ministry of health technical working group on childhood cancer where she has participated in development of management policy and guidelines. Her career goal has been to improve the research and clinical management of Sickle cell and other haematological disorders among children in sub-Saharan Africa.
Dr. Anne Akullo is a Pediatric Hematologist and oncologist and the current President of the Uganda Pediatric Association. She is the Associate Director of Clinical Operations for the Texas Children’s Hospital Global HOPE (TCH-GH) supported programs in Africa, where she leads the Dissemination and Implementation Science program. She is passionate about advocacy for child health and uses the UPA platform to promote high-impact policies for child health initiatives, such as the scale-up of sickle cell disease care on a national scale. Dr. Akullo completed her medical degree from Makerere University College of Health Sciences in 2005, followed by a specialization in Paediatrics and Child Health at Makerere University College of Health Sciences in 2014. She completed a Fellowship in Pediatric Hematology and Oncology at the same institution in 2020, supported by Texas Children’s Global HOPE. In addition, she has training and experience in Project Management, Implementation Science, and child health advocacy.
Dr. Irene Nzamu is the Head the Pediatric Haematology and Oncology Unit at Kenyatta National Hospital (KNH) and an honorary lecturer in the Department of Paediatrics in the University of Nairobi. Dr. Nzamu chairs the Hospital Blood Transfusion Committee and is deputy chair of the Hospital Ethics Committee. Nationally, Dr. Nzamu is the paediatric lead in the Focal Team for the Kenya National Cancer Control Strategy, is a member of the Ministry of Health’s Technical Working Group on Childhood Cancer and is actively involved in the establishment of the Kenya Pediatric Hematology and Oncology Society. She has served as Treasurer in the Kenya Society of Hematology Oncology (KESHO).
She earned her both her undergraduate and post graduate degrees from the University of Nairobi in 2005 and 2012 respectively. She completed the clinical fellowship in pediatric hematology and oncology training at Makerere University College of Health Sciences supported by Texas Children’s Global HOPE in 2020. She is a graduate of the African Leadership University Public Sector leadership fellowship and has undertaken several trainings from the University of Washington. She is passionate about providing evidence-based childhood cancer care targeting to bridge the gap in survival for children in Low Middle-Income Countries.
Dr. Ankunda is a Pediatric Hematologist and Oncologist based at the Cancer Center of Mbarara Regional Referral Hospital (MRRH) in Western Uganda. She previously served as a lecturer in the Department of Pediatrics and Child Health at Kabale University. She has spearheaded numerous childhood cancer awareness campaigns and conducted research focused on understanding the reasons for treatment abandonment among children with cancer. Her research interest is in solid tumors with a focus on understanding their biology in sub-Saharan Africa and improving the survival of children affected by solid tumors.
Dr. Ankunda earned her medical degree from Makerere University College of Health Sciences in 2010, followed by a specialization in Paediatrics and Child Health at Mbarara University of Science and Technology in 2017. She completed a Fellowship in Pediatric Hematology and Oncology at Makerere University College of Health Sciences in 2020, supported by Texas Children’s Global HOPE.
2019/2021 Cohort
Dr. Innocent Adebayo graduated with a medical degree (MBBS) from the University of Ilorin, Nigeria in 2006 and completed his residency in Paediatrics at the University of Abuja Teaching Hospital in 2018 with a Fellowship in Paediatrics (FMCPaed). Dr Adebayo’s completed his Paediatric Haematology and Oncology Fellowship Training in in 2021 from Makerere University College of Health Sciences, supported by the Texas Children’s Hospital Global HOPE program. He recently, in 2024, obtained a Fellowship in Palliative Medicine from the Institute of Palliative Medicine in India/St Christopher’s Hospice in London, United Kingdom. Dr Adebayo’s areas of interest are newborn screening, disease severity and hematopoietic stem cell transplantation in Sickle Cell Disease.
Dr. Rizine Mzikamanda is a specialist consultant in Pediatrics and Pediatric Hematology and Oncology at Baylor College of Medicine Children’s Foundation Malawi and Malawi National Cancer Center at Kamuzu Central Hospital (KCH). He is the Medical Director of the Global Hematology Oncology Pediatric Excellence Program in Malawi.
Dr. Mzikamanda completed his medical degree at the University of Malawi, College of Medicine (now Kamuzu University of Health Sciences- KUHES) in 2010, specialization in pediatrics at the University of Malawi, College of Medicine and University of Pretoria in 2018, and pediatric hematology and oncology fellowship at Makerere University in 2021 supported by Texas Children’s Global HOPE.
His vision is to become one of the leading clinical researchers in childhood leukemia and lymphoma in Sub-Saharan Africa (SSA). He is interested in developing locally appropriate treatment strategies for children in SSA and leading clinical trials in childhood cancer in this region over the next 5-10 years.
Dr. Catherine Muendo is a paediatric haematologist and oncologist working at the paediatric hematology and oncology department in Kenyatta National Hospital, Nairobi, Kenya. She is the head of unit at the Hemophilia comprehensive care centre at Kenyatta National Hospital. She is the vice chair of the Paediatric Hematology Oncology Society of Kenya.
She completed her medical degree at the University of Nairobi in 2010, and specialized training in paediatrics and child health at the University of Nairobi in 2017. She completed her paediatric hematology and oncology fellowship training at Makerere University College of Health Sciences, supported by Texas Children’s Global HOPE in 2021
Dr. Emma Nsalazi Bambi is a Congolese paediatrician and subspecialist in paediatric haematology and oncology, currently pursuing a Clinical Fellowship in Transfusion Medicine at McMaster University in Hamilton, Ontario, Canada. He holds a Master of Medicine in Paediatrics and Child Health from Makerere University, Uganda, and completed fellowship training in Paediatric Haematology and Oncology at Makerere University College of health Sciences Texas Children’s Global HOPE.in 2021.Dr. Bambi began his medical career after obtaining his Doctor of Medicine degree from Goma University in the Democratic Republic of Congo, and specialized training in pediatrics and child health at Makerere University.
Dr. Annet Nakirulu completed her medical degree (MBChB) at Kampala International University in 2012, higher diploma in Paediatric palliative care at Mildmay Uganda in 2016, specialization in paediatrics at Uganda Martyrs University Post graduate School Nsambya in 2019 and pediatric hematology and oncology fellowship at Makerere University College of Health Sciences in 2021
Dr. Annet Nakirulu is an associate consultant in Pediatric hematology at the Directorate of Pediatrics at Mulago National Referral Hospital. She provides evidence-based interdisciplinary medical care to children with sickle cell disease, plans and leads Paediatric Hematology Oncology education and outreach activities within the local and national community. She also participates in research, clinical quality improvement and program monitoring and evaluation activities for children with cancer and blood disorders at Mulago National Referral Hospital in collaboration with Texas Children’s Hospital Global HOPE Program.
Dr. Moses Karashani began his medical journey at China Medical University, where he received comprehensive training in general Paediatrics and Child health. Driven by a passion for advancing care in childhood blood disorders, he pursued a fellowship in Paediatric Haematology and Oncology at Makerere University College of Health Sciences Texas Children’s Global HOPE, completing it in 2021
Currently, Dr. Karashani serves at the Muhimbili National Hospital, Mloganzila campus in Tanzania. His clinical and research interests focus on the management of both benign and malignant haematologic conditions in children, aiming to improve outcomes through evidence-based approaches and targeted therapies. His work bridges the gap between bedside care and academic inquiry, making him a vital contributor to Tanzania’s growing Paediatric haematology and oncology landscape.
Cohort 2020/2022
Dr. Rose Munge is the Head of Unit -Paediatric Haematology and Oncology at Kenyatta University Teaching, Research and Referral Hospital (KUTRRH) and a lecturer in the Department of Paediatrics at Mount Kenya University. Dr. Munge played a key role in establishing paediatric oncology services at KUTRRH, culminating in the successful commissioning of the unit in 2024. She is also an active member of the Ministry of Health’s Technical Working Group on Childhood Cancer and is actively involved in the establishment of the Kenya Paediatric Haematology and Oncology Society. She earned her medical degree from the University of Nairobi in 2008 and completed specialized training in paediatrics at the same institution in 2015. In 2023, she completed a clinical fellowship in paediatric haematology and oncology at Makerere University College of Health Sciences supported by Texas Children’s Global HOPE. She also holds additional training in healthcare leadership from the University of Washington. Dr. Munge is passionate about expanding local fellowship training opportunities in paediatric haematology and oncology and is committed to advancing research-driven, high-quality cancer care for children across Kenya.
Dr. Catherine Nabaggala is a Paediatric Haematology and Oncology Specialist at Global HOPE (Haematology-Oncology Paediatric Excellence) Program in Uganda, based at Mulago National Referral Hospital. Dr Nabaggala completed her medical degree at Makerere University in 2004, specialized in Paediatrics at Makerere University Medical School in 2013 and Paediatric Haematology and Oncology fellowship at Makerere University in 2023 supported by Texas Children’s Global HOPE. Her vision is to scale up essential care for children with haematological disorders especially Sickle cell disease to the most vulnerable children living in primary health care settings.
Dr. Jennifer Zungu is the Director of The Texas Children’s Global HOPE program in Uganda. She holds a Bachelor of Medicine and Bachelor of Surgery from Makerere University, a Master of Medicine in Paediatrics and Child health from Mbarara University of Science and Technology (MUST), and a Diploma in Health care Management from The Kenya Institute of Management (KIM). She completed her clinical fellowship training in paediatric haematology and Oncology at Makerere University Supported by Texas Children’s Global HOPE.
Dr. Zungu is passionate and deeply committed to, driving better outcomes in Paediatric Haematology and Oncology. She uses her experience in healthcare management along with her clinical training in Paediatric Haematology-Oncology to advocate for evidence-based paediatric haematology and oncology care, best quality services, and excellent customer experience in the Public Healthcare sector in Uganda and beyond.
Dr. Joseph Gore is Head of the Pediatric Hematology & Oncology Unit at Alsabbah Children Hospital in Juba, and Senior Lecturer at the University of Juba, with a focus on improving sickle cell disease care & oncology services in South Sudan.
Makerere University School of Public Health (MakSPH), through the Africa-Europe Cluster of Research Excellence (CoRE) for Preparedness and Response to Pandemics and Shocks, has shared findings from its study of Uganda’s Mpox response with stakeholders in Kasese, Amuru, Nakasongola and Mayuge districts to strengthen district preparedness for future outbreaks.
The Africa-Europe CoRE is a partnership co-led by MakSPH and the Centre for Research on the Epidemiology of Disasters at UCLouvain, Belgium. It brings together universities in Africa and Europe to strengthen research, training and preparedness for pandemics and other public health shocks.
The district-level dissemination meetings, held from 10 to 14 August 2026, brought together more than 100 local government, health and security officials, Village Health Teams, implementing partners and community representatives. The meetings enabled stakeholders to validate the district-level findings, identify practical actions and provide feedback for the study’s final analysis and national dissemination.
Mr. Philliam Jabim shares the Mpox response study findings with participants during the dissemination meeting in Nakasongola District on 12 August 2026.
Uganda confirmed its first two Mpox cases on 24 July 2024 at Bwera Hospital in Kasese District. The Ministry of Health declared an outbreak on 2 August 2024. As documented in the study, the response involved health workers, communities, local governments, security agencies, political leaders, and implementing partners.
In response to the outbreak, a MakSPH research team led by Prof. Rhoda Wanyenze, Dr. Rawlance Ndejjo, Dr. Steven Kabwama and Mr. Douglas Bulafu conducted a study in May 2025 to assess Uganda’s Mpox response, including its policies, interventions, strategies and challenges, and generate lessons to inform recovery and strengthen preparedness for future public health emergencies.
Using purposive sampling, the research team conducted 20 key informant interviews and five focus group discussions in each of the four districts, drawing perspectives from western Uganda in Kasese, northern Uganda in Amuru, central Uganda in Nakasongola and eastern Uganda in Mayuge.
Participants and the MakSPH research team at the Mpox response study dissemination meeting in Nakasongola District on 12 August 2026.
The study, titled Assessment of the Mpox Response in Uganda: Documenting Challenges, Lessons and Innovations to Strengthen Emergency Preparedness and Response Capacities, was funded by the Government of Uganda through the Makerere UniversityResearch and Innovation Fund (Mak-RIF).
“This study is helping us move beyond recounting the Mpox response to identifying the actions that districts and national partners can take before the next outbreak. By validating the findings with stakeholders who led and experienced the response, we are ensuring that the evidence reflects local realities and can inform stronger surveillance, risk communication, coordination and community engagement,” said Mr. Bulafu, who led the MakSPH team during the dissemination meeting in Amuru.
Mr. Douglas Bulafu engages participants during the Mpox response study dissemination meeting in Amuru District on 10 August 2026.
In Amuru, the 10 August meeting brought together over 25 stakeholders from the district health team, political leadership, security agencies, Village Health Teams, implementing partners and the community. On the same day, a second MakSPH team, led by Mr. Keneth Sebukeera and Mr. Filimin Niyongabo, convened stakeholders in Kasese for a parallel validation meeting. The consultations then continued in Nakasongola on 12 August and concluded in Mayuge on 14 August, extending the study’s engagement across all four districts.
Across the districts, stakeholders said the results reflected their experience during the outbreak. They pointed to strengths in leadership, coordination, community engagement and partner support, while also describing gaps in documentation, logistics, diagnostic access, staffing, risk communication, public trust and continuity of essential health services.
They also noted inconsistent implementation of the World Health Organization (WHO) 7-1-7 target, which calls for detecting a suspected outbreak within seven days, notifying public health authorities within one day and completing early response actions within seven days.
The MakSPH research team, led by Mr. Keneth Sebukeera and Mr. Filimin Niyongabo, with participants during the Mpox response study dissemination meeting in Kasese District on 10 August 2026.
In Kasese, stakeholders highlighted gaps in documentation, financial and logistical resources, and human resources. They identified Village Health Teams and grassroots, religious and cultural leaders as important resources for community surveillance and risk communication. They called for stronger collaboration between technical and non-technical leaders, engagement with traditional healers, greater use of local radio for public sensitisation, and better facilitation of district epidemic response teams to reach distant communities.
Amuru participants called for proactive preparedness in the border district, citing misinformation and rumours as barriers to risk communication. They urged timely, accurate information from health workers and other authorities; training in disease surveillance and grant writing to strengthen capacity and resource mobilisation; and compassionate care, psychosocial support and community awareness to reduce stigma and support survivor reintegration.
During the meeting in Nakasongola, stakeholders identified Community Health Workers and Community Health Extension Workers as potential resources for strengthening community surveillance and addressing workforce shortages. Given the district’s position around Lake Kyoga and along the Kampala-South Sudan transit corridor, they also called for stronger documentation, note-taking and reporting, accurate real-time information, closer communication with the Ministry of Health, and collaboration among technical, political, religious and community leaders.
Ms. Eunice Vivian Asingo, Senior Nursing Officer at Nakasongola Health Centre IV, contributes to the discussion during the Mpox response study dissemination meeting in Nakasongola District on 12 August 2026.
Ms. Eunice Vivian Asingo, Senior Nursing Officer at Nakasongola Health Centre IV, called for a permanent, adequately resourced outbreak-management centre to help protect routine services during future epidemics. “We appeal for better facilities to manage epidemics and outbreaks. At Nakasongola Health Centre IV, spaces previously used for outbreak management have been repurposed for other services, and we have limited staff. During the Mpox response, colleagues assigned to manage patients later returned to the general team, creating fear among staff already under pressure,” she said.
In Mayuge, Dr. Basembeza highlighted leadership, coordination and surveillance structures operating from district to community level as important factors in the response. He said the structures enabled the district to receive and respond quickly to community alerts. “Whenever there is a rumour or an alert, we are able to respond. Within 20 minutes, we had a response because of the structure we have,” Dr. Basembeza said.
Based on the findings, the research team recommends increased preparedness financing, stronger community engagement, decentralised diagnostic services through stronger district laboratory capacity, and improved health information and research systems.
Across the four districts, stakeholders reaffirmed that trusted community structures and coordinated action across sectors are essential to strengthening outbreak preparedness.
Every academic year, a new group of students enters Makerere University School of Public Health (MakSPH) with different professional backgrounds, questions and ambitions. For the School, each cohort adds to a growing community of professionals and researchers shaping public health practice, policy and research in Uganda and beyond.
On Friday, 7 August 2026, MakSPH held its orientation for newly admitted students for the 2026/2027 academic year at the MakSPH Auditorium. The orientation introduced students to the School’s academic programmes, leadership, departments, academic administration, student support services and expectations for university life.
For this academic year, ending July 2027, Makerere University admitted more than 370 students to academic programmes hosted at MakSPH. The intake comprised 75 students in the Bachelor of Environmental Health Science, the School’s only bachelor’s programme, 277 across the nine master’s programmes, and 21 across the two doctoral programmes, PhD by Research and PhD by Coursework and Research.
Dean Prof. Rhoda Wanyenze (centre) with MakSPH staff, student leaders and new students during orientation for the 2026/2027 academic year.
The master’s intake includes 103 students in the Master of Public Health by Distance Education, the highest enrolment for the year, followed by 59 in the Master of Public Health Full-Time. The remaining students joined programmes in Biostatistics, Environmental and Occupational Health, Health Informatics, Health Services Research, Monitoring and Evaluation, Nutrition, and Public Health Disaster Management. Together, the programmes reflect the breadth of knowledge and skills needed to address public health challenges and bring together students pursuing further training from diverse professional backgrounds.
Welcoming the new cohort, MakSPH Dean Prof. Rhoda Wanyenze urged students to approach their studies with purpose, discipline, and resilience, and focus on what they would be able to do with the knowledge and skills they acquire.
“Please find time to enjoy your journey. I know you’re looking ahead to exams and so many other pressures, but let this journey also be one that you enjoy in terms of what you learn and how you grow, so that you leave here better, not because of the paper that you took but because of the capability that you pick up during your time with us.”
MakSPH Dean Prof. Rhoda Wanyenze addresses new students at orientation for the 2026/2027 academic year, 7 August 2026, MakSPH Auditorium, urging them to value capability over paper.
The Dean’s message speaks to the different reasons students are beginning their journeys at MakSPH. For some, the opportunity is to build on professional experience and strengthen their capacity in roles they already hold. Among them is Dr. Judith Nalukwago, a dental surgeon, former 85th Vice Guild President of Makerere University, and Makindye Division III Lord Councillor, who serves as Executive Secretary for Education, Gender and Public Health at City Hall and the Office of the Lord Mayor.
“I am back here to study a Master’s in Public Health. I am very excited. I have a clinical background and have been practising as a clinician, and it has been a joyful experience. But when I joined the journey of leadership, there were challenges because, as Executive Secretary for Public Health in Kampala, we deal with everyday people’s health challenges,” said Dr. Nalukwago, adding:
“Now I am in management and leadership, and that posed a challenge to me as an individual. I asked myself, what course can I do to add to my skills? Where can I gain skills that can help me overcome this challenge while I am dealing with people? And I remembered that we have the School of Public Health at Makerere University.”
Watch: Dr. Judith Nalukwago on why she returned to MakSPH for a Master’s in Public Health:
Her experience during the Ebola response, when she served on the task force, further highlighted the need for broader public health knowledge. She said the training would strengthen her ability to contribute to policy and public health management, particularly in her role at City Hall, where councillors develop policies, bylaws, and ordinances.
For Mr. John Othieno, the motivation is similarly grounded in applying his training to practical problems. A Software Engineering graduate who previously completed a Master’s in Health Informatics at MakSPH, he has returned to pursue a PhD under the Department of Health Policy, Planning and Management. His research focuses on using technology and health informatics to address health-system challenges, including the adoption of picture archiving and communication systems for managing healthcare imaging and data. He said he wants his research to produce solutions that can be applied beyond academia.
“I purposed that, in my academic journey, I would not do research for the sake of having it gather dust on the shelves, but that it would actually be actionable research that can be translated into action, into solutions for our population,” he said.
Watch: Mr. John Othieno on why he returned to MakSPH to pursue a PhD in Public Health:
Nalukwago and Othieno reflect the diverse professional backgrounds that come together at MakSPH, where training, research, and community engagement have been central to the School’s work for over seven decades. Their journeys point to a sustained impact on public health education, seen not only in enrolment and graduate numbers but in the skills and expertise those graduates carry into policy, research, and health systems across Uganda and the region. At the close of the 2024/2025 academic year, MakSPH enrolled 1,140 students across 12 degree programmes, more than 90 percent of them in postgraduate training.
At Makerere University’s 76th Graduation Ceremony on 25 February 2026, MakSPH presented 231 graduates, comprising seven doctoral, 195 master’s and 29 bachelor’s graduates, adding to the health workforce within the region. Among the graduates was Dr. Harriet Aber, who completed her PhD on child substance use in Uganda’s health system and shared her experience with the new cohort during the orientation. She spoke candidly about the demands of postgraduate study and the need to remain positive through its challenges.
Dr. Harriet Aber, a MakSPH PhD graduate, shares her postgraduate journey with new students at orientation, 7 August 2026, MakSPH Auditorium, urging them to maintain a positive attitude through the challenges ahead.
“It’s not a rosy journey. You’re going to have so many moments where you celebrate, where you’re happy about something, but there are also several moments when maybe you’re stuck with the paper, you have to respond to comments, the proposal is not moving, the concept is not clear. Throughout all those processes, one of the things that you just have to maintain is having a positive attitude,” Aber affirmed.
Her experience offered the new cohort a glimpse of the journey ahead, while Prof. Wanyenze’s message focused on how they could make the most of it. The Dean urged students to plan ahead, pursue research opportunities, think independently, and use artificial intelligence responsibly, while seeking mentorship and making full use of the support and opportunities available at the School.
“Our students are our colleagues, and they are our future workmates. Many of them have ended up staying with us. And I know many of you are going to stay with us in the School,” the Dean said, urging students to take seriously the relationships they build with their classmates and faculty, because “we are a network that’s bound together in the same profession.”
On 5th August 2026, Makerere University College of Health Sciences (MakCHS) hosted the Director of the NIH Fogarty International Center (FIC), Dr. Steven Schiff, for a visit highlighting the College’s research, training and institutional partnerships supported through the National Institutes of Health (NIH)/Fogarty International Center.
The visit included engagements at MakCHS and Mulago National Referral Hospital, bringing together College leadership, Directors of teaching hospitals affiliated with MakCHS, research investigators and trainees. In attendance were Dr. Joseph Kagaayi who represented the Dean of the Makerere University School of Public Health, Dr. Elias Kumbakumba, Dean of the School of Health Sciences at Mbarara University of Science and Technology (MUST) and Dr. Cissy Kityo Mutuluuza, Executive Director, Joint Clinical Research Centre (JCRC).
A key focus of the visit was the impact of D43 research training programmes supported by NIH/FIC. Principal Investigators presented examples of how the programmes have strengthened research capacity, developed new scientific expertise, supported postgraduate training and contributed to health research and policy in Uganda.
Welcoming Dr. Schiff, Professor Bruce Kirenga, Principal-MakCHS provided an overview of the College, its history, academic programmes, research priorities and extensive network of teaching and research sites. The College, Uganda’s premier centres for health professional education, currently brings together four schools: the School of Medicine, School of Biomedical Sciences, School of Health Sciences, School of Dentistry, alongside a range of research centres and specialised programmes.
Professor Kirenga highlighted the growing breadth of research at MakCHS, including infectious diseases, non-communicable diseases, translational medicine, population health, mental health, digital health, implementation science, biomedical sciences, genomics, bioinformatics and data science.
Prof. Bruce Kirenga (Standing) makes his remarks.
CURRENT D43 PROJECTS AT MAKCHS
No.
Award Title
Principal Investigator
1
Reducing the Impact of Rheumatic Heart Disease across the Life Span: The Impact Program
Prof. Nelson Sewankambo
2
Enhancing Research capacity for Sickle Cell Disease and related NCDs across the Lifespan in Uganda. “Enrich Project”
Prof. Sarah Kiguli
3
Scaling Up advanced genomics and bioinformatics Research training in paediatric HIV/AIDS in Uganda – SURGE
Dr. Kyobe, Samuel
4
Training in Malaria Epidemiology, Translational Research, and Implementation Science to Strengthen Malaria Policy and Control in Uganda
Prof. Moses Robert Kamya
5
Strengthening behavioral and social science research capacity to address overlapping stigma, social and psychological challenges among people with HIV in Uganda
Prof. Moses Robert Kamya
6
Training in non-communicable diseases epidemiological, data science and Implementation Science research to strengthen evidence-based interventions, policy and control in Uganda
Assoc. Prof. Bruce James Kirenga
7
Building Implementation Science Capacity at Makerere University to Strengthen the Response to the HIV/AIDS Epidemic in Uganda
Prof. Moses Robert Kamya
8
Training in Malaria Epidemiology, Translational Research, and Implementation Science to Strengthen Malaria Policy and Control in Uganda
Prof. Moses Robert Kamya
9
Harnessing Health Data Science capacity to strengthen evidence-based interventions, policy and response to the HIV/AIDS Epidemic in Uganda (H-DATA)
Prof. David Patrick Kateete
From research training to real-world impact
Presentations from D43 Principal Investigators demonstrated how sustained NIH/FIC investment has supported researchers at different stages of their careers while contributing to evidence that can inform health programmes and policy.
In malaria research, trainees have been involved in studies examining the effectiveness of interventions such as insecticide-treated bed nets and the immunological consequences of reduced malaria transmission. Researchers are also investigating how malaria risk and immunity change when transmission is interrupted, generating evidence that can help inform strategies for sustaining the gains made through malaria control.
The implementation science portfolio provided another example of research translating into measurable health outcomes. One study examining enhanced counselling and peer support among young people living with HIV in south-western Uganda reported improvements in HIV-related outcomes, demonstrating the potential of locally-led research to strengthen service delivery.
Researchers in behavioural and social sciences have also been supported to investigate mental health and other health outcomes, illustrating the multidisciplinary nature of MakCHS research and the importance of combining biomedical, clinical and social science approaches.
Building capacity in specialised and emerging fields
The presentations also showcased the role of NIH/FIC-supported programmes in creating expertise in areas that were previously limited or unavailable within Uganda.
A programme focused on HIV research among pregnant women, children and adolescents has supported postgraduate and short-course training in areas including clinical trial design, pharmacokinetics, biostatistics, behavioural science, regulatory and ethical considerations, and implementation science.
Other programmes have contributed to the development of expertise in bioinformatics, genomics and data science, including the establishment and strengthening of postgraduate programmes. Researchers are increasingly applying artificial intelligence and machine learning to complex biomedical and HIV datasets, with the goal of generating evidence that can be translated into policy and practice.
Dr. Cissy Kityo Mutuluuza, Executive Director of the JCRC highlighted emerging work in gene and cell therapy under the NIH/FIC supported project Building Gene Therapy Capacity in Uganda implemented at JCRC. She explained that the programme includes efforts to establish sustainable research and training capacity for HIV cure research in Uganda. The programme brings together institutions in Uganda and international partners, with an emphasis on developing locally relevant expertise, infrastructure and research capability.
Dr. Cissy Kityo Mutuluuza (Standing) highlights JCRC’s work.
Strengthening institutions and developing future leaders
Beyond individual research projects, speakers emphasised the broader institutional impact of Fogarty-supported training.
Over the years, NIH/FIC-supported collaborations have contributed to the development of postgraduate programmes, research laboratories, specialised scientific disciplines and networks of researchers across Uganda. Trainees have progressed into academic and research leadership positions, with some becoming professors, programme leaders and advisors contributing to national health initiatives.
The programmes have also supported short courses, mentorship, international research placements and collaborations designed to enable Ugandan scientists to develop advanced skills and return to strengthen research and training at home.
Presenters stressed the importance of moving beyond individual training to building institutions capable of sustaining research programmes, mentoring future scientists, managing complex studies and translating findings into health interventions.
Research serving Uganda’s health system
The visit also underscored the close relationship between MakCHS research and Uganda’s health system. Researchers and faculty contribute to national programmes in areas including HIV, tuberculosis, malaria, vaccines, maternal and child health and other public health priorities.
Evidence generated through research has helped inform national guidelines, programmes and policy discussions, while College researchers and teaching hospitals continue to provide expertise during public health emergencies and disease outbreaks.
The speakers noted that partnerships such as those supported by NIH/FIC are most valuable when they create lasting local capacity — enabling Ugandan institutions and scientists to generate and use evidence to address the country’s health priorities.
A partnership built on shared learning
Dr. Steven Schiff makes his presentation.
In his engagement with the College, Dr. Schiff reflected on the longstanding relationship between NIH/Fogarty-supported programmes and Ugandan researchers. He acknowledged the depth of expertise and experience that has developed through years of collaboration and emphasised the value of partnerships that support scientific exchange and capacity building in both directions.
Dr. Schiff noted that the presentations demonstrated impact of the partnerships which extends well beyond the number of people trained. Investments in researchers have helped establish new academic programmes, strengthen laboratories and research infrastructure, expand multidisciplinary collaborations and create a growing generation of scientists able to lead research in Uganda and internationally.
The visit therefore provided an opportunity not only to showcase ongoing work, but also to reflect on the evolution of research capacity at MakCHS and its contribution to Uganda’s health priorities.
As MakCHS continues to expand its research portfolio into emerging areas such as artificial intelligence, genomics, precision medicine, translational science and advanced therapeutics, the College reaffirmed the importance of strategic partnerships in developing the people, systems and infrastructure needed to turn scientific discoveries into improved health outcomes.
General5 days ago
General2 weeks ago
General7 days ago
General1 week ago
Computing & IS1 week ago